Arsenic suppresses gene expression in promyelocytic leukemia cells partly through Sp1 oxidation by Wen-Chien Chou, Hsuan-Yu Chen, Sung-Liang Yu, Linzhao.

Slides:



Advertisements
Similar presentations
Figure 5 ISOX and vorinostat partially restore splicing pattern in DM1 patient-derived fibroblasts. (A) ISOX and vorinostat partially rescue mis-splicing.
Advertisements

Volume 11, Issue 4, Pages (April 2007)
Antiangiogenic antithrombin down-regulates the expression of the proangiogenic heparan sulfate proteoglycan, perlecan, in endothelial cells by Weiqing.
by Hong Hao, Huiling Qi, and Manohar Ratnam
by Pascal Gelebart, Mona Anand, Hanan Armanious, Anthea C
Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor–κB and IκBα kinase in human multiple myeloma cells, leading to.
The C/EBPδ tumor suppressor is silenced by hypermethylation in acute myeloid leukemia by Shuchi Agrawal, Wolf-Karsten Hofmann, Nicola Tidow, Mathias Ehrich,
Neuronal RNA Granules Neuron
by Mineo Iwata, Lynn Graf, Norihiro Awaya, and Beverly Torok-Storb
The Ewing's sarcoma oncoprotein EWS/FLI induces a p53-dependent growth arrest in primary human fibroblasts  Stephen L Lessnick, Caroline S Dacwag, Todd.
FOG-1 represses GATA-1-dependent FcϵRI β-chain transcription: transcriptional mechanism of mast-cell-specific gene expression in mice by Keiko Maeda, Chiharu.
CD74 induces TAp63 expression leading to B-cell survival
Overexpression of survivin in primary ATL cells and sodium arsenite induces apoptosis by down-regulating survivin expression in ATL cell lines by Xiao-Fang.
Sarah A. Best, Amy N. Nwaobasi, Chrysalyne D. Schmults, Matthew R
MafB negatively regulates RANKL-mediated osteoclast differentiation
Activation of ATF4 mediates unwanted Mcl-1 accumulation by proteasome inhibition by Jinsong Hu, Nana Dang, Eline Menu, Elke De Bryune, Dehui Xu, Ben Van.
by Christopher J. Ott, Nadja Kopp, Liat Bird, Ronald M
Intermittent cyclic mechanical tension promotes endplate cartilage degeneration via canonical Wnt signaling pathway and E-cadherin/β-catenin complex cross-talk 
by Wu-Guo Deng, Ying Zhu, and Kenneth K. Wu
Volume 41, Issue 6, Pages (March 2011)
Sarah A. Best, Amy N. Nwaobasi, Chrysalyne D. Schmults, Matthew R
Inhibition of glycogen synthase kinase-3 activity leads to epigenetic silencing of nuclear factor κB target genes and induction of apoptosis in chronic.
by Guang Yang, Shu-Ching Huang, Jane Y. Wu, and Edward J. Benz
Induction of Somatic Hypermutation Is Associated with Modifications in Immunoglobulin Variable Region Chromatin  Caroline J. Woo, Alberto Martin, Matthew.
Cell-surface CD74 initiates a signaling cascade leading to cell proliferation and survival by Diana Starlets, Yael Gore, Inbal Binsky, Michal Haran, Nurit.
Volume 27, Issue 22, Pages e5 (November 2017)
by Gregory H. Underhill, David George, Eric G. Bremer, and Geoffrey S
Volume 16, Issue 6, Pages (December 2004)
Stimulation of the B-cell receptor activates the JAK2/STAT3 signaling pathway in chronic lymphocytic leukemia cells by Uri Rozovski, Ji Yuan Wu, David.
Rose-Anne Romano, Barbara Birkaya, Satrajit Sinha 
Interferon- Activates Multiple STAT Proteins and Upregulates Proliferation-Associated IL-2R, c-myc, and pim-1 Genes in Human T Cells by Sampsa Matikainen,
Pim-1 is up-regulated by constitutively activated FLT3 and plays a role in FLT3-mediated cell survival by Kyu-Tae Kim, Kristin Baird, Joon-Young Ahn, Paul.
Spleen Tyrosine Kinase Mediates EGFR Signaling to Regulate Keratinocyte Terminal Differentiation  Nan-Lin Wu, Duen-Yi Huang, Li-Fang Wang, Reiji Kannagi,
Polina Iakova, Samir S Awad, Nikolai A Timchenko  Cell 
Volume 14, Issue 19, Pages (October 2004)
Induction of Somatic Hypermutation Is Associated with Modifications in Immunoglobulin Variable Region Chromatin  Caroline J. Woo, Alberto Martin, Matthew.
MUC1 Oncoprotein Stabilizes and Activates Estrogen Receptor α
Volume 71, Issue 9, Pages (May 2007)
Impaired Proteasome Function Activates GATA3 in T Cells and Upregulates CTLA-4: Relevance for Sézary Syndrome  Heather M. Gibson, Anjali Mishra, Derek.
Volume 125, Issue 4, Pages (May 2006)
Yifang Chen, Devendra S. Mistry, George L. Sen 
Ashton Breitkreutz, Lorrie Boucher, Mike Tyers  Current Biology 
Xiaolong Wei, Hai Xu, Donald Kufe  Cancer Cell 
GLI2 Is a Regulator of β-Catenin and Is Associated with Loss of E-Cadherin, Cell Invasiveness, and Long-Term Epidermal Regeneration  Eleni Pantazi, Emilios.
Profiling Motility Signal-Specific Genes in Primary Human Keratinocytes  Chieh-Fang Cheng, Jianhua Fan, Balaji Bandyopahdhay, Dennis Mock, Shengxi Guan,
Volume 17, Issue 12, Pages (December 2016)
MUC1 Oncoprotein Stabilizes and Activates Estrogen Receptor α
Volume 13, Issue 6, Pages (June 2013)
The therapeutic effects of HDAC and mTOR inhibitors are mediated by the suppression of class I HDACs and require oxidative stress. The therapeutic effects.
T exosomes bind MAdCAM-1 via RA-increased integrin α4β7.
Volume 16, Issue 12, Pages (June 2006)
Resistance of Human Melanoma Cells Against the Death Ligand TRAIL Is Reversed by Ultraviolet-B Radiation via Downregulation of FLIP  Elke Zeise, Michael.
Volume 19, Issue 6, Pages (September 2005)
Inhibition of PAX3 by TGF-β Modulates Melanocyte Viability
H2B Ubiquitylation Promotes RNA Pol II Processivity via PAF1 and pTEFb
Impact of RTEL1 variants on telomere maintenance.
Volume 26, Issue 3, Pages (May 2007)
Transcriptional Repression of miR-34 Family Contributes to p63-Mediated Cell Cycle Progression in Epidermal Cells  Dario Antonini, Monia T. Russo, Laura.
Robin M. Ricke, Anja-Katrin Bielinsky  Molecular Cell 
Glia maturation factor-γ regulates murine macrophage iron metabolism and M2 polarization through mitochondrial ROS by Wulin Aerbajinai, Manik C. Ghosh,
Volume 15, Issue 1, Pages (July 2004)
Decreased expression of cell cycle– and apoptosis-related genes in Aml1-excised leukemia cell. Decreased expression of cell cycle– and apoptosis-related.
Defective RAB1B-related megakaryocytic ER-to-Golgi transport in RUNX1 haplodeficiency: impact on von Willebrand factor by Gauthami Jalagadugula, Lawrence.
Volume 17, Issue 3, Pages (October 2016)
Volume 31, Issue 6, Pages (December 2009)
Nucleoporin Nup98 Associates with Trx/MLL and NSL Histone-Modifying Complexes and Regulates Hox Gene Expression  Pau Pascual-Garcia, Jieun Jeong, Maya.
Volume 15, Issue 1, Pages (July 2008)
PU.1 Expression Delineates Heterogeneity in Primary Th2 Cells
Pirh2 represses p73-dependent transactivation.
Autophagy Activation Is Mediated by the Secretion of T3Es.
Presentation transcript:

Arsenic suppresses gene expression in promyelocytic leukemia cells partly through Sp1 oxidation by Wen-Chien Chou, Hsuan-Yu Chen, Sung-Liang Yu, Linzhao Cheng, Pan-Chyr Yang, and Chi V. Dang Blood Volume 106(1):304-310 July 1, 2005 ©2005 by American Society of Hematology

Expression profile of arsenic-responsive genes. Expression profile of arsenic-responsive genes. (Left) Gene symbols, UniGene numbers, and change ratios of expression as revealed by microarray analysis of the 26 highly responsive genes for RT-PCR after hydrogen peroxide treatment or NAC rescue experiment. Three genes, denoted with asterisks, were not changed more than 6-fold; hence, they are omitted from the heat map. u indicates up-regulated; d, down-regulated. (Right) Heat map demonstrating the arsenicinduced changes in expression (at least 6-fold) of 106 down-regulated and 177 up-regulated genes. Wen-Chien Chou et al. Blood 2005;106:304-310 ©2005 by American Society of Hematology

Arsenic induces ROS production. Arsenic induces ROS production. (A) ROS detection by flow cytometry using dihydrorhodamine 123 as a probe. Pretreatment with NAC significantly blunts ROS production after arsenic treatment. (B) ROS detection by luminol chemiluminescence. Cotreatment with NAC significantly blunts arsenic-induced ROS. Experiments were repeated twice with similar results. The y-axis represents arbitrary units of signal intensity, and the x-axis represents duration of measurement in minutes. Wen-Chien Chou et al. Blood 2005;106:304-310 ©2005 by American Society of Hematology

Genes responsive to hydrogen peroxide and arsenic. Genes responsive to hydrogen peroxide and arsenic. Nineteen of 26 genes are represented in this figure. Among 9 arsenic up-regulated genes, 2 (CDw52 and ALOX5AP) are also up-regulated by hydrogen peroxide. Among 17 arsenic down-regulated genes, 7 (C17, TERT, MYC, GJA1, SOX18, CCNA1, and STAB1) are also down-regulated by hydrogen peroxide (only 5 were presented in this figure); see Figure 4. Values are averages of triplicates. Independent experiments were performed at least twice with similar results. Wen-Chien Chou et al. Blood 2005;106:304-310 ©2005 by American Society of Hematology

Effect of NAC on arsenic-induced gene expression. Effect of NAC on arsenic-induced gene expression. (A-B) Certain arsenic-induced gene expression changes can be blunted by at least 50% with NAC cotreatment (reversed). There are also genes whose expression is altered by arsenic but that remain unaffected by NAC (not reversed). Some genes were responsive (more than 2-fold) to NAC alone without arsenic and hence were categorized as being “not informative.” Values are averages of triplicates. Independent experiments were performed at least twice with similar results. (C) Schematic diagram showing that 6 of 26 genes tested are directly related to ROS production (common area of the 3 circles). Blue highlights down-regulated genes, and red highlights up-regulated genes by arsenic treatment. The 9 genes in the area common to the red and blue circles denote those with consensus change of expression after treatment with arsenic or hydrogen peroxide. The 12 genes in the area common to the red and black circles are those whose expression change after arsenic treatment could be reversed by NAC. Wen-Chien Chou et al. Blood 2005;106:304-310 ©2005 by American Society of Hematology

In vivo Sp1 binding to the promoters of hTERT, c-Myc, and C17, as determined by ChIP assay. In vivo Sp1 binding to the promoters of hTERT, c-Myc, and C17, as determined by ChIP assay. (A, left) Nuclear extracts from the same samples used in ChIP were immunoblotted with c-Myc and Sp1 antibodies. Coomassie blue staining served as loading control. (Right) SYBR green real-time PCR shows diminished Sp1 and c-Myc binding on the hTERT promoter after arsenic (0.75 μM for 12 days) exposure. Mock indicates no nuclear extract in the reaction; No Ab, omission of antibody in the immunoprecipitation procedures. HGF antibody was used as a control IgG. PCR products obtained at 35 cycles and resolved on agarose gel are shown below the graph. (B-C) SYBR green real-time PCR quantification of ChIP using anti-Sp1 antibody shows a significant decrease in Sp1 binding in the promoters of MYC (B) and C17 (C) after arsenic treatment. Error bars represent standard deviations from triplicate experiments. Wen-Chien Chou et al. Blood 2005;106:304-310 ©2005 by American Society of Hematology

Sp1 deglycosylation after arsenic treatment. Sp1 deglycosylation after arsenic treatment. (A) Sp1 glycosylation was decreased after arsenic treatment, as detected by immunoblotting (IB) with O-linked GlcNAc-specific antibody (110.6 Ab) after immunoprecipitation (IP) with an anti-Sp1 antibody. The Sp1 antibody-detected signals serve as loading controls. (B) Sp1 deglycosylation was induced by glucose starvation (24 hours) or treatment with DON (40 μM for 24 hours). (C) Decrease in Sp1 glycosylation did not diminish in vivo Sp1 binding on the hTERT promoter, as determined by chromatin immunoprecipitation. (D) Deglycosylation of Sp1 did not result in decreased hTERT expression, as determined by quantitative RT-PCR. Error bars represent standard deviations from triplicate experiments. Wen-Chien Chou et al. Blood 2005;106:304-310 ©2005 by American Society of Hematology

Hydrogen peroxide treatment decreases in vivo Sp1 binding to MYC and C17 promoters. Hydrogen peroxide treatment decreases in vivo Sp1 binding to MYC and C17 promoters. (A) ChIP assay showed decrease of Sp1 binding on the promoters of c-Myc and C17 after oxidation by hydrogen peroxide treatment. (B) Cell fractionation after hydrogen peroxide treatment showed no decrease in the level of Sp1, which was exclusively nuclear. Cytosolic heat shock protein 90 (Hsp90) was used as a control for fractionation. γ-Tubulin was used as a loading control. Wen-Chien Chou et al. Blood 2005;106:304-310 ©2005 by American Society of Hematology

Arsenic and hydrogen peroxide treatments result in oxidation of Sp1 protein. Arsenic and hydrogen peroxide treatments result in oxidation of Sp1 protein. Immunoprecipitated (IP) Sp1 from control, arsenic, or hydrogen peroxide-treated samples was incubated with BIAM, and this was followed by detection by immunoblotting (IB) with streptavidin-conjugated HRP. The same immunoprecipitate was subjected to detection by Sp1 antibody as a loading control. BIAM/Sp1 signal ratios represent relative BIAM incorporation. Wen-Chien Chou et al. Blood 2005;106:304-310 ©2005 by American Society of Hematology